Alphina Therapeutics Inc. has described nicotinamide phosphoribosyltransferase (NAmPRTase; Nampt) inhibitors reported to be useful for the treatment of cancer, and autoimmune, inflammatory and ...

RPT1G is not only the first hyperbolic NAMPT inhibitor but also the first ... trial will enable us to initiate our subsequent ...

Neutropenia in individuals with a congenital defect or patients with cancer who are undergoing chemotherapy ... (G-CSFR), the authors proposed that NAMPT activates an autoregulatory loop, whereby ...